| Aminolevulinic-acid | hsa00230 | Purine metabolism | 4.48E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa00830 | Retinol metabolism | 3.19E-02 | 1 | P00325 | ADH1B | More | |
| Aminolevulinic-acid | hsa01040 | Biosynthesis of unsaturated fatty acids | 7.30E-03 | 2 | P22307, Q9H5J4 | SCP2, ELOVL6 | More | |
| Aminolevulinic-acid | hsa01212 | Fatty acid metabolism | 7.30E-03 | 2 | Q9H5J4, P22307 | ELOVL6, SCP2 | More | |
| Aminolevulinic-acid | hsa01240 | Biosynthesis of cofactors | 4.79E-02 | 2 | P13716, P14618 | ALAD, PKM2 | More | |
| Aminolevulinic-acid | hsa01522 | Endocrine resistance | 6.51E-03 | 3 | Q08828, P51828, P31751 | ADCY1, ADCY7, AKT2 | More | |
| Aminolevulinic-acid | hsa04015 | Rap1 signaling pathway | 3.69E-04 | 5 | P15498, Q08828, P51828, P31751, P0DP23 | VAV1, ADCY1, ADCY7, AKT2, CALM1 | More | |
| Aminolevulinic-acid | hsa04020 | Calcium signaling pathway | 1.42E-02 | 3 | Q08828, P0DP23, P51828 | ADCY1, CALM1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04022 | cGMP-PKG signaling pathway | 2.66E-03 | 4 | P31751, Q08828, P51828, P0DP23 | AKT2, ADCY1, ADCY7, CALM1 | More | |
| Aminolevulinic-acid | hsa04024 | cAMP signaling pathway | 6.94E-05 | 5 | Q08828, P51828, P31751, P0DP23, P15498 | ADCY1, ADCY7, AKT2, CALM1, VAV1 | More | |
| Aminolevulinic-acid | hsa04062 | Chemokine signaling pathway | 7.23E-03 | 4 | P15498, Q08828, P51828, P31751 | VAV1, ADCY1, ADCY7, AKT2 | More | |
| Aminolevulinic-acid | hsa04072 | Phospholipase D signaling pathway | 1.67E-02 | 3 | P31751, Q08828, P51828 | AKT2, ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04114 | Oocyte meiosis | 1.67E-02 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04211 | Longevity regulating pathway | 6.51E-03 | 3 | P31751, Q08828, P51828 | AKT2, ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04213 | Longevity regulating pathway - multiple species | 2.91E-03 | 3 | P31751, Q08828, P51828 | AKT2, ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.17E-03 | 4 | Q08828, P51828, P31751, P0DP23 | ADCY1, ADCY7, AKT2, CALM1 | More | |
| Aminolevulinic-acid | hsa04270 | Vascular smooth muscle contraction | 9.93E-03 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04371 | Apelin signaling pathway | 1.09E-03 | 4 | P31751, Q08828, P51828, P0DP23 | AKT2, ADCY1, ADCY7, CALM1 | More | |
| Aminolevulinic-acid | hsa04380 | Osteoclast differentiation | 6.51E-03 | 3 | Q9NQC7, P23458, P31751 | CYLD, JAK1, AKT2 | More | |
| Aminolevulinic-acid | hsa04540 | Gap junction | 3.73E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04611 | Platelet activation | 5.11E-03 | 3 | P31751, Q08828, P51828 | AKT2, ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04625 | C-type lectin receptor signaling pathway | 3.91E-03 | 3 | Q9NQC7, P31751, P0DP23 | CYLD, AKT2, CALM1 | More | |
| Aminolevulinic-acid | hsa04630 | JAK-STAT signaling pathway | 2.91E-03 | 3 | P31751, P23458, Q13651 | AKT2, JAK1, IL10RA | More | |
| Aminolevulinic-acid | hsa04662 | B cell receptor signaling pathway | 2.41E-02 | 2 | P31751, P15498 | AKT2, VAV1 | More | |
| Aminolevulinic-acid | hsa04664 | Fc epsilon RI signaling pathway | 2.41E-02 | 2 | P31751, P15498 | AKT2, VAV1 | More | |
| Aminolevulinic-acid | hsa04713 | Circadian entrainment | 2.91E-03 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04720 | Long-term potentiation | 3.73E-02 | 2 | P0DP23, Q08828 | CALM1, ADCY1 | More | |
| Aminolevulinic-acid | hsa04723 | Retrograde endocannabinoid signaling | 4.48E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04724 | Glutamatergic synapse | 3.73E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04725 | Cholinergic synapse | 5.11E-03 | 3 | Q08828, P51828, P31751 | ADCY1, ADCY7, AKT2 | More | |
| Aminolevulinic-acid | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.91E-03 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Aminolevulinic-acid | hsa04910 | Insulin signaling pathway | 3.04E-02 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | |
| Aminolevulinic-acid | hsa04911 | Insulin secretion | 2.41E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04912 | GnRH signaling pathway | 5.11E-03 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Aminolevulinic-acid | hsa04913 | Ovarian steroidogenesis | 1.85E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04914 | Progesterone-mediated oocyte maturation | 6.51E-03 | 3 | Q08828, P51828, P31751 | ADCY1, ADCY7, AKT2 | More | |
| Aminolevulinic-acid | hsa04915 | Estrogen signaling pathway | 2.66E-03 | 4 | Q08828, P51828, P31751, P0DP23 | ADCY1, ADCY7, AKT2, CALM1 | More | |
| Aminolevulinic-acid | hsa04916 | Melanogenesis | 1.41E-03 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04918 | Thyroid hormone synthesis | 4.48E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04921 | Oxytocin signaling pathway | 1.42E-02 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04923 | Regulation of lipolysis in adipocytes | 2.69E-04 | 3 | Q08828, P51828, P31751 | ADCY1, ADCY7, AKT2 | More | |
| Aminolevulinic-acid | hsa04925 | Aldosterone synthesis and secretion | 3.91E-03 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Aminolevulinic-acid | hsa04926 | Relaxin signaling pathway | 8.11E-03 | 3 | P31751, Q08828, P51828 | AKT2, ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04927 | Cortisol synthesis and secretion | 1.85E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04934 | Cushing syndrome | 3.73E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04935 | Growth hormone synthesis, secretion and action | 6.51E-03 | 3 | Q08828, P51828, P31751 | ADCY1, ADCY7, AKT2 | More | |
| Aminolevulinic-acid | hsa04970 | Salivary secretion | 9.02E-04 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Aminolevulinic-acid | hsa04971 | Gastric acid secretion | 1.41E-03 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Aminolevulinic-acid | hsa04972 | Pancreatic secretion | 2.41E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa04976 | Bile secretion | 1.85E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa05032 | Morphine addiction | 2.41E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Aminolevulinic-acid | hsa05135 | Yersinia infection | 2.24E-02 | 3 | Q14161, P15498, P31751 | GIT2, VAV1, AKT2 | More | |
| Aminolevulinic-acid | hsa05142 | Chagas disease | 4.48E-02 | 2 | Q08828, P31751 | ADCY1, AKT2 | More | |
| Aminolevulinic-acid | hsa05145 | Toxoplasmosis | 1.67E-02 | 3 | P23458, P31751, Q13651 | JAK1, AKT2, IL10RA | More | |
| Aminolevulinic-acid | hsa05152 | Tuberculosis | 9.49E-03 | 4 | P0DP23, P23458, P31751, Q13651 | CALM1, JAK1, AKT2, IL10RA | More | |
| Aminolevulinic-acid | hsa05163 | Human cytomegalovirus infection | 2.17E-04 | 6 | P31751, P0DP23, Q08828, P51828, P23458, Q13651 | AKT2, CALM1, ADCY1, ADCY7, JAK1, IL10RA | More | |
| Aminolevulinic-acid | hsa05164 | Influenza A | 3.67E-02 | 3 | P31751, P23458, Q9UBU9 | AKT2, JAK1, NXF1 | More | |
| Aminolevulinic-acid | hsa05166 | Human T-cell leukemia virus 1 infection | 3.02E-02 | 4 | P23458, Q08828, P51828, P31751 | JAK1, ADCY1, ADCY7, AKT2 | More | |
| Aminolevulinic-acid | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.24E-02 | 3 | P31751, P23458, P0DP23 | AKT2, JAK1, CALM1 | More | |
| Aminolevulinic-acid | hsa05168 | Herpes simplex virus 1 infection | 2.09E-02 | 4 | Q9UBU9, P23458, P31751, Q6NUN9 | NXF1, JAK1, AKT2, ZNF746 | More | |
| Aminolevulinic-acid | hsa05200 | Pathways in cancer | 1.65E-02 | 5 | P23458, P31751, Q08828, P51828, P0DP23 | JAK1, AKT2, ADCY1, ADCY7, CALM1 | More | |
| Aminolevulinic-acid | hsa05212 | Pancreatic cancer | 2.41E-02 | 2 | P31751, P23458 | AKT2, JAK1 | More | |
| Aminolevulinic-acid | hsa05214 | Glioma | 1.85E-02 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | |
| Aminolevulinic-acid | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.48E-02 | 2 | P31751, P23458 | AKT2, JAK1 | More | |
| Aminolevulinic-acid | hsa05414 | Dilated cardiomyopathy | 4.48E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
